BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10913583)

  • 1. Positive effect of bumetanide on contractile activity of ventricular cardiomyocytes.
    Kelso E; McDermott B; Silke B; Spiers P
    Eur J Pharmacol; 2000 Jul; 400(1):43-50. PubMed ID: 10913583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of loop diuretics.
    Brater DC
    Drugs; 1991; 41 Suppl 3():14-22. PubMed ID: 1712712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of loop diuretics on cholinergic neurotransmission in human airways in vitro.
    Verleden GM; Pype JL; Deneffe G; Demedts MG
    Thorax; 1994 Jul; 49(7):657-63. PubMed ID: 8066560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
    Welzel B; Schmidt R; Kirchhoff L; Gramer M; Löscher W
    Epilepsy Behav; 2023 Feb; 139():109057. PubMed ID: 36586153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torasemide, but not frusemide, increases intracellular cAMP and cGMP content in the aorta of the renal hypertensive rat.
    Yamanaga K; Uchida T; Kido H; Hayashi K; Watanabe M
    J Pharm Pharmacol; 1992 Jan; 44(1):64-5. PubMed ID: 1350633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T; Krämer B; Müller GA
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loop diuretics block calcium currents in cardiac cells.
    Shimoni Y
    J Mol Cell Cardiol; 1991 Nov; 23(11):1209-13. PubMed ID: 1803016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torasemide for the treatment of heart failure.
    Ishido H; Senzaki H
    Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):127-32. PubMed ID: 18537599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.
    Uechi M; Matsuoka M; Kuwajima E; Kaneko T; Yamashita K; Fukushima U; Ishikawa Y
    J Vet Med Sci; 2003 Oct; 65(10):1057-61. PubMed ID: 14600341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
    Manolis A; Kallistratos M; Doumas M
    Curr Pharm Des; 2021; 27(23):2714-2721. PubMed ID: 33823773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loop diuretics: comparison of torsemide, furosemide, and bumetanide.
    Chen BP
    Conn Med; 1996 Jun; 60(6):343-5. PubMed ID: 8706428
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC
    Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The loop diuretic torasemide interferes with endothelin-1 actions in the aorta of hypertensive rats.
    Fortuño A; Muñiz P; Zalba G; Fortuño MA; Díez J
    Nephrol Dial Transplant; 2001; 16 Suppl 1():18-21. PubMed ID: 11369815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscle.
    Stanke F; Devillier P; Bréant D; Chavanon O; Sessa C; Bricca G; Bessard G
    Br J Clin Pharmacol; 1998 Dec; 46(6):571-5. PubMed ID: 9862246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bumetanide and furosemide on the thick ascending limb of Henle's loop of rabbits and rats perfused in vitro.
    Imai M
    Eur J Pharmacol; 1977 Feb; 41(4):409-16. PubMed ID: 844482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Rudy DW; Gehr TW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):39-47. PubMed ID: 8033493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.